Nasdaq: LFCR
Lifecore Biomedical insiders
The officers, directors and 10% owners of Lifecore Biomedical, Inc. who hold the most stock, valued at the live LFCR price.
$6.37
LFCR today −$30K (−0.47%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their LFCR stock
- $83.0M
- Market value
- $242M
- Held by ranked insiders
- 34.2%
Insiders by value of LFCR holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Wynnefield Capital, Inc. Profit Sharing Plan | 10% owner | 4,703,216 | $30.0M | 12.4% | Corporate |
| 2 | Wynnefield Capital Management LLC | 10% owner | 4,411,033 | $28.1M | 11.6% | Corporate |
| 3 | Wynnefield Small Cap Value Offshore Fund LTD | 10% owner | 3,783,287 | $24.1M | 9.94% | Corporate |
| 4 | Jason Aryeh | Director | 69,967 | $446K | 0.18% | 3493rd |
| 5 | Matthew E. Korenberg | Director | 69,967 | $446K | 0.18% | 6393rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Lifecore Biomedical; see each profile for the filing.